Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2026-08-14 16:48:18 ET · period of report 2026-08-12 · accession 0001724310-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-14 16:48 | 2026-08-12 | DNLI | Watts Ryan J. | Pres, CEO, Dir | G - Gift | $0.00 | -32.2K | 2.12M | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-12 | G | D | 32,220 | $0.00 | 2,120,384 | I See footnote | — | — | (F1) Reflects an in-kind charitable contribution of 32,220 shares of DNLI to a donor advised fund. (F2) The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. |